Dyadic International Inc (DYAI) posted an 80% productivity gain in its animal-free transferrin program and began product shipments, but flat revenue and liquidity concerns cloud the outlook.
Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.
Support from global health organizations highlights continued development of Dyadic’s C1 and Dapibus platforms for
Imperium AI Founder and CEO Shazir Mucklai will lead an internal review of Dyadic’s biotechnology platforms,
Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing With Global Health Support to Help Turn AI-Designed DNA Into Life-Saving Products
Imperium AI CEO Shazir Mucklai on Major Potential in Dyadic (NASDAQ: DYAI), Calls Board Meeting to Discuss Next Steps
This is the newest page. Registered accounts read further back.